Clinical Trials
3 trialsNCT06931717 2026-06-01
ARCH
ETOP IBCSG Partners Foundation
Phase 3 Recruiting
NCT07058012 2026-05-15
EMPIRE
NSABP Foundation Inc
Phase 2 Recruiting
NCT06616584 2026-05-05
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
SWOG Cancer Research Network
Phase 2/3 Recruiting